| scholarly article | Q13442814 |
| P356 | DOI | 10.1046/J.1365-2567.1998.00579.X |
| P698 | PubMed publication ID | 9767471 |
| P50 | author | Sang-Jun Ha | Q37368920 |
| Seong-Beom Lee | Q60310510 | ||
| P2093 | author name string | H S Shin | |
| C M Kim | |||
| Y C Sung | |||
| P2860 | cites work | Purification to homogeneity and partial characterization of cytotoxic lymphocyte maturation factor from human B-lymphoblastoid cells | Q24295111 |
| Production of natural killer cell stimulatory factor (interleukin 12) by peripheral blood mononuclear cells | Q24338274 | ||
| Coexpression of two distinct genes is required to generate secreted bioactive cytotoxic lymphocyte maturation factor | Q24338518 | ||
| Tight control of gene expression in mammalian cells by tetracycline-responsive promoters | Q24564850 | ||
| High-efficiency transformation of mammalian cells by plasmid DNA | Q27860469 | ||
| Transcriptional activation by tetracyclines in mammalian cells | Q28303934 | ||
| Switch from a type 2 to a type 1 T helper cell response and cure of established Leishmania major infection in mice is induced by combined therapy with interleukin 12 and Pentostam | Q28368077 | ||
| Development of TH1 CD4+ T cells through IL-12 produced by Listeria-induced macrophages | Q29618421 | ||
| Interleukin-12: a proinflammatory cytokine with immunoregulatory functions that bridge innate resistance and antigen-specific adaptive immunity | Q29619700 | ||
| Influence of interleukin 12 on p53 peptide vaccination against established Meth A sarcoma | Q34577679 | ||
| Identification and purification of natural killer cell stimulatory factor (NKSF), a cytokine with multiple biologic effects on human lymphocytes | Q36356764 | ||
| Adenovirus-mediated interleukin-12 gene therapy for metastatic colon carcinoma | Q37247348 | ||
| Doxycycline-mediated quantitative and tissue-specific control of gene expression in transgenic mice | Q37303897 | ||
| Gene gun-mediated skin transfection with interleukin 12 gene results in regression of established primary and metastatic murine tumors | Q37513598 | ||
| Antitumor effects of interleukin-12 (IL-12): applications for the immunotherapy and gene therapy of cancer. | Q40508210 | ||
| Interleukin-12: a cytokine produced by antigen-presenting cells with immunoregulatory functions in the generation of T-helper cells type 1 and cytotoxic lymphocytes | Q40651348 | ||
| Interleukin-12 and its role in the generation of TH1 cells | Q40712406 | ||
| Effective eradication of established murine tumors with IL-12 gene therapy using a polycistronic retroviral vector. | Q41335213 | ||
| Fibroblasts genetically engineered to secrete interleukin 12 can suppress tumor growth and induce antitumor immunity to a murine melanoma in vivo. | Q41503342 | ||
| Natural killer cell stimulatory factor (interleukin 12 [IL-12]) induces T helper type 1 (Th1)-specific immune responses and inhibits the development of IL-4-producing Th cells | Q41564337 | ||
| Antitumor and antimetastatic activity of interleukin 12 against murine tumors | Q41906195 | ||
| IL-12 induces IFN-gamma expression and secretion in mouse peritoneal macrophages. | Q42445043 | ||
| Contrasting in vitro lymphocyte chemotactic activity of the hydroxyl enantiomers of 12-hydroxy-5,8,10,14-eicosatetraenoic acid | Q42848458 | ||
| Eradication of murine bladder carcinoma by intratumor injection of a bicistronic adenoviral vector carrying cDNAs for the IL-12 heterodimer and its inhibition by the IL-12 p40 subunit homodimer | Q45148456 | ||
| Antitumor efficacy of adenocarcinoma cells engineered to produce interleukin 12 (IL-12) or other cytokines compared with exogenous IL-12. | Q52042067 | ||
| Cytotoxic NK1.1 Ag+ alpha beta T cells with intermediate TCR induced in the liver of mice by IL-12. | Q54173684 | ||
| Regulation of human lymphocyte proliferation by a heterodimeric cytokine, IL-12 (cytotoxic lymphocyte maturation factor) | Q67695881 | ||
| Interleukin-4 is chemotactic for mouse macrophages | Q68052203 | ||
| Systemic administration of rIL-12 induces complete tumor regression and protective immunity: response is correlated with a striking reversal of suppressed IFN-gamma production by anti-tumor T cells | Q70801399 | ||
| Cytokine and chemokine expression in tumors of mice receiving systemic therapy with IL-12 | Q70844146 | ||
| Liver NK1.1+ CD4+ alpha beta T cells activated by IL-12 as a major effector in inhibition of experimental tumor metastasis | Q71049413 | ||
| Injection of complementary DNA encoding interleukin-12 inhibits tumor establishment at a distant site in a murine renal carcinoma model | Q71400886 | ||
| IL-12-engineered dendritic cells serve as effective tumor vaccine adjuvants in vivo | Q71871168 | ||
| Cancer immunotherapy of established tumors with IL-12. Effective delivery by genetically engineered fibroblasts | Q71961070 | ||
| Dendritic cells produce IL-12 and direct the development of Th1 cells from naive CD4+ T cells | Q72191659 | ||
| Recombinant IL-12 administration induces tumor regression in association with IFN-gamma production | Q72686394 | ||
| Interleukin-12 is chemotactic for natural killer cells and stimulates their interaction with vascular endothelium | Q72698910 | ||
| IL-12 induces T helper 1-directed antitumor response | Q73271308 | ||
| Requirement for Valpha14 NKT cells in IL-12-mediated rejection of tumors | Q73889862 | ||
| P433 | issue | 1 | |
| P921 | main subject | interleukins | Q194908 |
| P304 | page(s) | 156-163 | |
| P577 | publication date | 1998-09-01 | |
| P1433 | published in | Immunology | Q15754984 |
| P1476 | title | Rapid recruitment of macrophages in interleukin-12-mediated tumour regression | |
| P478 | volume | 95 |
| Q40410230 | Administration route- and immune cell activation-dependent tumor eradication by IL12 electrotransfer |
| Q44078795 | Biodegradable polymer-based interleukin-12 gene delivery: role of induced cytokines, tumor infiltrating cells and nitric oxide in anti-tumor activity |
| Q24806391 | Efficient delivery of small interfering RNA for inhibition of IL-12p40 expression in vivo |
| Q52013629 | Engineering N-glycosylation mutations in IL-12 enhances sustained cytotoxic T lymphocyte responses for DNA immunization. |
| Q45419597 | IL-12 deficiency transiently improves viral clearance during the late phase of respiratory tract infection with influenza A virus in mice |
| Q47854639 | Immunohistochemical expression of interleukin-4, -6, -8, and -12 in inflammatory cells in surrounding invasive front of oral squamous cell carcinoma |
| Q33713444 | Interleukin-37 mediates the antitumor activity in hepatocellular carcinoma: role for CD57+ NK cells |
| Q82542686 | Mice overexpressing p40 in lungs have reduced leucocyte influx and slightly impaired resistance during tuberculosis |
| Q45422073 | Sustained E2 antibody response correlates with reduced peak viremia after hepatitis C virus infection in the chimpanzee |
Search more.